{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:53:52Z","timestamp":1752231232457,"version":"3.37.3"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060236"],"award-info":[{"award-number":["82060236"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2019GXNSFDA245032"],"award-info":[{"award-number":["2019GXNSFDA245032"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.msard.2023.105120","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T09:59:46Z","timestamp":1699610386000},"page":"105120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The impact of COVID-19 on a Southern Chinese cohort with neuromyelitis optica spectrum disorders"],"prefix":"10.1016","volume":"81","author":[{"given":"Jian","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaodan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yishuang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manli","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuowei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayuan","family":"Lao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9055-9873","authenticated-orcid":false,"given":"Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.msard.2023.105120_bib0001","doi-asserted-by":"crossref","first-page":"357","DOI":"10.5603\/PJNNS.a2021.0051","article-title":"Multiple sclerosis immunomodulatory therapies tested for effectiveness in COVID-19","volume":"55","author":"Adamczyk","year":"2021","journal-title":"Neurol. Neurochir. Pol."},{"issue":"3","key":"10.1016\/j.msard.2023.105120_bib0002","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/annrheumdis-2020-218946","article-title":"Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis","volume":"80","author":"Akiyama","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.msard.2023.105120_bib0003","first-page":"e36323","article-title":"New onset multiple sclerosis post-COVID-19 vaccination and correlation with possible predictors in a case-control study","volume":"15","author":"Alluqmani","year":"2023","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.msard.2023.105120_bib0004","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001060","article-title":"Clinical features of COVID-19 on patients with neuromyelitis optica spectrum disorders","volume":"8","author":"Apostolos-Pereira","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.msard.2023.105120_bib0005","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s40120-022-00418-9","article-title":"Multiple sclerosis and neuromyelitis optica spectrum disorder: onset following acute COVID-19 infection, a case series","volume":"12","author":"Avila","year":"2023","journal-title":"Neurol. Ther."},{"issue":"1","key":"10.1016\/j.msard.2023.105120_bib0006","doi-asserted-by":"crossref","first-page":"fcab297","DOI":"10.1093\/braincomms\/fcab297","article-title":"Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis","volume":"4","author":"Badenoch","year":"2022","journal-title":"Brain Commun."},{"issue":"7960","key":"10.1016\/j.msard.2023.105120_bib0007","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/d41586-023-01437-8","article-title":"COVID's future: mini-waves rather than seasonal surges","volume":"617","author":"Callaway","year":"2023","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.msard.2023.105120_bib0008","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s11739-022-02934-w","article-title":"Delirium in hospitalized patients with COVID-19 pneumonia: a prospective, cross-sectional, cohort study","volume":"17","author":"Callea","year":"2022","journal-title":"Intern. Emerg. Med."},{"issue":"8","key":"10.1016\/j.msard.2023.105120_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084154","article-title":"Adverse events in NMOSD therapy","volume":"23","author":"Giglhuber","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.msard.2023.105120_bib0010","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s13054-020-03200-1","article-title":"Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients","volume":"24","author":"Helms","year":"2020","journal-title":"Crit. Care"},{"issue":"2","key":"10.1016\/j.msard.2023.105120_bib0011","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200082","article-title":"Effects of the COVID-19 pandemic on patients with NMO spectrum disorders and MOG-antibody-associated diseases: COPANMO(G)-study","volume":"10","author":"Hummert","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.msard.2023.105120_bib0012","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001141","article-title":"Risk of getting COVID-19 in people with multiple sclerosis: a case-control study","volume":"9","author":"Iaffaldano","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2023.105120_bib0013","article-title":"Association of COVID-19 pandemic and rate of cognitive decline in patients with dementia and mild cognitive impairment: a cross-sectional study","volume":"7","author":"Ismail","year":"2021","journal-title":"Gerontol. Geriatr. Med."},{"issue":"10","key":"10.1016\/j.msard.2023.105120_bib0014","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1111\/ene.14951","article-title":"Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival","volume":"28","author":"Jakub\u00edkov\u00e1","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2023.105120_bib0015","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s10072-023-06676-1","article-title":"Evaluation of the safety profile of COVID-19 vaccines in patients with MS, NMOSD, and MOGAD","volume":"44","author":"Kim","year":"2023","journal-title":"Neurol. Sci."},{"issue":"14","key":"10.1016\/j.msard.2023.105120_bib0016","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1177\/1352458516687403","article-title":"Predictors of response to first-line immunosuppressive therapy in neuromyelitis optica spectrum disorders","volume":"23","author":"Kim","year":"2017","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.msard.2023.105120_bib0017","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/pcn.13508","article-title":"Neuropsychiatric aspects of long COVID: a comprehensive review","volume":"77","author":"Kubota","year":"2023","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.msard.2023.105120_bib0018","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/BOR.0000000000000776","article-title":"COVID-19 and autoimmune diseases","volume":"33","author":"Liu","year":"2021","journal-title":"Curr. Opin. Rheumatol."},{"issue":"10","key":"10.1016\/j.msard.2023.105120_bib0019","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1111\/ene.14612","article-title":"Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders","volume":"28","author":"Louapre","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2023.105120_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.652111","article-title":"Dysregulation of systemic immunity in aging and dementia","volume":"15","author":"Lutshumba","year":"2021","journal-title":"Front. Cell Neurosci."},{"issue":"1","key":"10.1016\/j.msard.2023.105120_bib0021","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01648-20","article-title":"The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells","volume":"95","author":"Matsuyama","year":"2020","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.msard.2023.105120_bib0022","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neurol.2022.11.004","article-title":"Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: a systematic review","volume":"179","author":"Mirmosayyeb","year":"2023","journal-title":"Rev. Neurol. (Paris)"},{"issue":"1","key":"10.1016\/j.msard.2023.105120_bib0023","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5603\/PJNNS.a2023.0008","article-title":"COVID-19 and autoimmune diseases of the nervous system - an update","volume":"57","author":"Morawiec","year":"2023","journal-title":"Neurol. Neurochir. Pol."},{"issue":"10","key":"10.1016\/j.msard.2023.105120_bib0024","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1177\/1352458520948231","article-title":"Multiple sclerosis management during the COVID-19 pandemic","volume":"26","author":"Moss","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2023.105120_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1077236","article-title":"Immune responses in mildly versus critically ill COVID-19 patients","volume":"14","author":"Nasrollahi","year":"2023","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.msard.2023.105120_bib0026","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001057","article-title":"COVID-19 in patients with neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody disease in North America: from the COViMS registry","volume":"8","author":"Newsome","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2023.105120_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117225","article-title":"Neuromyelitis optica spectrum disorders","volume":"420","author":"Paul","year":"2021","journal-title":"J. Neurol. Sci."},{"year":"2023","series-title":"Overview of National COVID Infections","key":"10.1016\/j.msard.2023.105120_bib0028"},{"issue":"3","key":"10.1016\/j.msard.2023.105120_bib0029","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S2213-2600(20)30552-X","article-title":"Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study","volume":"9","author":"Pun","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.msard.2023.105120_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102245","article-title":"Evaluation of COVID-19 infection in patients with Neuromyelitis optica spectrum disorder (NMOSD): a report from Iran","volume":"44","author":"Sahraian","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5","key":"10.1016\/j.msard.2023.105120_bib0031","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.gerinurse.2021.03.007","article-title":"Dementia as a mortality predictor among older adults with COVID-19: a systematic review and meta-analysis of observational study","volume":"42","author":"Saragih","year":"2021","journal-title":"Geriatr. Nurs."},{"issue":"4\u20135","key":"10.1016\/j.msard.2023.105120_bib0032","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/13524585231151948","article-title":"Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2","volume":"29","author":"Schreiner","year":"2023","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2023.105120_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103399","article-title":"The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: a milder course?","volume":"58","author":"Sen","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.105120_bib0034","first-page":"1","article-title":"SARS-CoV-2 susceptibility and COVID-19 illness course and outcome in people with pre-existing neurodegenerative disorders: systematic review with frequentist and Bayesian meta-analyses","author":"Smadi","year":"2023","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.msard.2023.105120_bib0035","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.26028","article-title":"Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis","volume":"89","author":"Sormani","year":"2021","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2023.105120_bib0036","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/pcn.13481","article-title":"Neurological post-acute sequelae of SARS-CoV-2 infection","volume":"77","author":"Takao","year":"2023","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"9","key":"10.1016\/j.msard.2023.105120_bib0037","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1177\/13524585211069068","article-title":"The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments","volume":"28","author":"Tur","year":"2022","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.msard.2023.105120_bib0038","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2023.105120_bib0039","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.resinv.2019.12.005","article-title":"Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells","volume":"58","author":"Yamaya","year":"2020","journal-title":"Respir. Investig."},{"issue":"6","key":"10.1016\/j.msard.2023.105120_bib0040","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1007\/s00415-023-11692-4","article-title":"COVID-19 infection after SARS-CoV-2 mRNA vaccination in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD patients during the Omicron subvariant BA.1\/2 wave in Singapore","volume":"270","author":"Yeo","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2023.105120_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.657037","article-title":"The impact of COVID-19 on patients with neuromyelitis optica spectrum disorder beyond infection risk","volume":"12","author":"Yin","year":"2021","journal-title":"Front. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2023.105120_bib0042","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1111\/ene.14690","article-title":"COVID-19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response","volume":"28","author":"Zabalza","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2023.105120_bib0043","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12016-022-08921-5","article-title":"Risk and protective factors for COVID-19 morbidity, severity, and mortality","volume":"64","author":"Zhang","year":"2023","journal-title":"Clin. Rev. Allergy Immunol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823006211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823006211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T01:02:16Z","timestamp":1719968536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034823006211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":43,"alternative-id":["S2211034823006211"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2023.105120","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of COVID-19 on a Southern Chinese cohort with neuromyelitis optica spectrum disorders","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2023.105120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105120"}}